Stock 300255 HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Equities

300255

CNE1000016C2

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-14 pm EDT 		5-day change 1st Jan Change
11.3 CNY +0.89% Intraday chart for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. -6.61% -13.14%
Apr. 28 Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 14 Yang Minghuan completed the acquisition of 5.8% stake in Hebei Changshan Biochemical Pharmaceutical Co., Ltd. from Gao Shuhua. CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 3,824 5,086 5,693 7,472 5,036 11,957
Enterprise Value (EV) 1 3,788 5,373 6,543 8,667 6,729 14,053
P/E ratio 27.3 x 22.7 x 22.9 x 32.5 x 274 x -9.64 x
Yield 0.68% 0.24% - 0.32% 0.09% -
Capitalization / Revenue 2.31 x 2.46 x 2.41 x 2.52 x 2.16 x 8.48 x
EV / Revenue 2.29 x 2.59 x 2.77 x 2.92 x 2.88 x 9.96 x
EV / EBITDA 11.7 x 15.1 x 15.4 x 22.8 x 40.8 x -35.2 x
EV / FCF -259 x -17.8 x -13.8 x -18.4 x -13.5 x 24.4 x
FCF Yield -0.39% -5.62% -7.22% -5.42% -7.43% 4.09%
Price to Book 1.52 x 1.87 x 1.99 x 2.43 x 1.65 x 6.47 x
Nbr of stocks (in thousands) 934,967 934,967 921,145 919,061 919,061 919,061
Reference price 2 4.090 5.440 6.180 8.130 5.480 13.01
Announcement Date 4/22/19 4/28/20 4/28/21 4/19/22 4/21/23 4/28/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,653 2,071 2,364 2,968 2,336 1,410
EBITDA 1 324.5 356.1 423.8 379.7 164.8 -399.8
EBIT 1 280.4 304 368.8 324.1 108 -474.2
Operating Margin 16.97% 14.68% 15.6% 10.92% 4.62% -33.62%
Earnings before Tax (EBT) 1 171.4 261.2 301.6 260.4 18.12 -1,232
Net income 1 140 225.3 252.8 233.6 17.51 -1,240
Net margin 8.47% 10.88% 10.7% 7.87% 0.75% -87.93%
EPS 2 0.1500 0.2400 0.2700 0.2500 0.0200 -1.350
Free Cash Flow 1 -14.64 -301.9 -472.6 -469.9 -499.9 575.4
FCF margin -0.89% -14.57% -19.99% -15.83% -21.4% 40.79%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 0.0280 0.0130 - 0.0260 0.005000 -
Announcement Date 4/22/19 4/28/20 4/28/21 4/19/22 4/21/23 4/28/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 286 850 1,195 1,692 2,096
Net Cash position 1 35.6 - - - - -
Leverage (Debt/EBITDA) - 0.804 x 2.006 x 3.148 x 10.27 x -5.242 x
Free Cash Flow 1 -14.6 -302 -473 -470 -500 575
ROE (net income / shareholders' equity) 5.33% 8.48% 9.01% 7.81% 0.33% -51.4%
ROA (Net income/ Total Assets) 4.75% 4.88% 5.41% 4.15% 1.2% -5.57%
Assets 1 2,945 4,616 4,671 5,629 1,457 22,248
Book Value Per Share 2 2.690 2.900 3.100 3.340 3.330 2.010
Cash Flow per Share 2 1.090 0.6000 0.5200 0.5900 0.8700 0.2600
Capex 1 235 163 200 308 431 239
Capex / Sales 14.21% 7.89% 8.45% 10.38% 18.46% 16.97%
Announcement Date 4/22/19 4/28/20 4/28/21 4/19/22 4/21/23 4/28/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD. Stock Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
-13.14% 1.42B
CSL LIMITED Stock CSL Limited
-1.26% 89.46B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+2.76% 40.74B
BIOGEN INC. Stock Biogen Inc.
-8.92% 33.03B
UCB Stock UCB
+55.32% 24.68B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-16.50% 15.12B
INCYTE CORPORATION Stock Incyte Corporation
-8.84% 12.81B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-12.11% 11.79B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-43.61% 11.64B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+7.79% 8.9B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 300255 Stock
  4. Financials Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW